QIAGEN and McKesson Agree to Distribute QIAstat-Dx Syndromic Testing Solution to Smaller Hospitals and Other Select Segments in the United States

Agreement adds commercial firepower for QIAGEN's U.S. launch of the next generation platform for syndromic insights initially for respiratory conditions QIAGEN (NYSE:QGEN; Frankfurt Prime Standard...